Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness, diagnosis, and research for thymidine kinase 2 deficiency (TK2d).

As well as correcting registration errors and the accompanying risk of in-breeding, genotyping identifies problem animals ...

For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene ...

According to a new research, a groundbreaking gene therapy has successfully restored hearing in both children and adults with ...

After 10 years of being raised at Saigon Zoo and Botanical Gardens, a rare Bengal white tiger named Ngo Khong has passed away ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

Use of lasers for dermatologic conditions in pediatric patients brings challenges, from psychosocial and informed consent issues to pain management.

One-time surgical application of genetically engineered autologous keratinocyte sheets provides significant closure and pain ...

HealthDay News — For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene zamikeracel, an autologous COL7A1 gene-modified cellular ...

In July 2025, Novartis Pharmaceuticals conducted a Phase III multi-center, single dose (1.2 x 1014 vector genomes), ...

Tayma, 9, struggles with the most severe version of Epidermolysis Bullosa, a rare, agonizing disorder that causes skin to blister and crack ...

Nectarines: There is a common misconception that nectarines are a cross between a plum and a peach, but that’s not at all the ...